Last Updated: May 10, 2026

Claims for Patent: 9,744,302


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,744,302
Title:Needle assisted jet injection device having reduced trigger force
Abstract:An injector includes a trigger mechanism including: a trigger member disposed about an axis having an aperture and a protrusion, and a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom, the ram assembly further having a trigger engagement member configured to engage the aperture of the trigger member when the trigger member is in a pre-firing condition; an energy source associated with the ram for powering the ram to expel the medicament; and a user-operable firing-initiation member having an aperture engaged with the protrusion of the trigger member and operable for causing an axial translation of the trigger member in a proximal direction from the pre-firing condition to a firing condition in which the trigger engagement member is released from the retaining portion to allow the energy source to fire the ram.
Inventor(s):Michael Travanty
Assignee: Antares Pharma Inc
Application Number:US14/178,199
Patent Claims: 1. An injector, comprising: a medicament container containing medicament, the medicament being at least one of testosterone or a derivative thereof; a trigger mechanism including: a trigger member disposed about an axis, the trigger member having a trigger member opening and a trigger member protrusion, and a ram assembly having a ram configured to pressurize the medicament container for expelling the medicament therefrom, the ram assembly further having a trigger engagement member configured to engage the trigger member opening when the trigger member is in a pre-firing condition; an energy source associated with the ram and configured to powering the ram to expel the medicament; and a user-operable guard including a firing-initiation member having a guard aperture engaged with the trigger member protrusion, the firing-initiation member operable for causing an axial translation of the trigger member in a proximal direction from the pre-firing condition to a firing condition in which the trigger engagement member is disengaged from the trigger member opening to allow the energy source to fire the ram.

2. The injector of claim 1, wherein the testosterone or a derivative thereof includes an ester of testosterone.

3. The injector of claim 1, wherein the testosterone or derivative thereof includes testosterone cypionate.

4. The injector of claim 1, wherein the testosterone or derivative thereof includes testosterone enanthate.

5. The injector of claim 1, wherein the guard aperture is slidingly engaged with the trigger member protrusion.

6. The injector of claim 1, wherein the ram assembly is of unitary construction.

7. The injector of claim 1, wherein the injector is configured to inject at least 0.5 ml of the testosterone or derivative thereof in about 14 seconds or less.

8. The injector of claim 1, wherein the injector is configured to inject at least 0.5 ml of the testosterone or derivative thereof in about 5 seconds to about 15 seconds.

9. The injector of claim 1, wherein the energy source expels the testosterone or derivative thereof at a stream velocity of at least about 100 centimeters per second.

10. The injector of claim 1, further comprising a container support that is configured for holding the medicament container during injection, and wherein the ram assembly is configured to engage the container support to lock-out the injector after an injection.

11. The injector of claim 10, wherein proximal movement of the user-operable guard is blocked by the ram assembly when the injector is locked-out.

12. The injector of claim 1, wherein a pre-firing color gamut is visible from an exterior of the injector in the pre-firing condition, the injector further comprising: a housing including a window; and an indicator having an indicator color that is absent from the pre-firing color gamut, the indicator color being hidden from view within the housing in the pre-firing condition, wherein in the firing condition, the indicator color is visible through the window from an exterior of the injector for indicating the firing condition.

13. The injector of claim 12, wherein the ram assembly includes the indicator.

14. The injector of claim 13, wherein the ram assembly entirely occludes the window in the firing condition.

15. The injector of claim 1, further comprising an end cap, said end cap comprising a ram holding member that axially retains the ram assembly in a proximal position against action of the energy source in the pre-firing condition.

16. The injector of claim 15, wherein the ram holding member engages the trigger engagement member to axially retain the ram assembly in the proximal position against action of the energy source in the pre-firing condition.

17. The injector of claim 16, wherein in the firing condition, the ram assembly is disengaged from the trigger member opening, and the energy source overcomes the engagement between the trigger engagement member and the ram holding member.

18. The injector of claim 16, wherein the ram holding member includes a projection that includes a bulge and a groove that are configured to engaged the trigger engagement member, and the trigger member opening retains the engagement of the trigger engagement member with the bulge and groove in the pre-firing condition.

19. The injector of claim 16, further comprising, a latch retention angle defined by the axis and a contact surface of the ram holding member and the trigger engagement member.

20. The injector of claim 19, wherein the latch retention angle is between about 35° and about 45°.

21. The injector of claim 19, wherein the latch retention angle is between about 75° and about 85°.

22. The injector of claim 1, further comprising: an injector housing, wherein the firing-initiation member includes a skin-contacting member disposed at a distal end of the injector, the skin-contacting member being movable proximally with respect to the housing when a force is applied to the skin-contacting member at the distal end of the injector, the firing-initiation member being associated with the trigger member and configured to cause the axial translation of the trigger member in a proximal direction from the pre-firing condition to the firing condition upon a proximal movement of the skin-contacting member with respect to housing.

23. The injector of claim 22, wherein the skin-contacting member is coupled to the guard, the guard being configured to expose a needle connected to the medicament container upon the proximal movement of the skin-contacting member.

24. The injector of claim 23, wherein the needle is in fluid communication with the medicament container for injecting the medicament expelled therefrom when the ram is fired.

25. The injector of claim 23, wherein the energy source and the needle are configured for jet injecting the medicament through the needle.

26. The injector of claim 25, wherein the energy source is configured to pressurize the medicament from about 90 p.s.i. to and about 600 p.s.i.

27. The injector of claim 25, wherein the energy source and needle are configured for injecting the medicament at an average velocity of at least about 1,000 cm/sec within the needle.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.